Lee's Pharmaceutical Holdings Limited (HKG:0950)
1.210
-0.030 (-2.42%)
Apr 2, 2026, 4:08 PM HKT
HKG:0950 Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 349.9 | 216.85 | 171 | 189.3 | 277.53 |
Cash & Short-Term Investments | 349.9 | 216.85 | 171 | 189.3 | 277.53 |
Cash Growth | 61.36% | 26.81% | -9.67% | -31.79% | -33.05% |
Accounts Receivable | 190.71 | 161.1 | 84.59 | 111.28 | 168.32 |
Other Receivables | 175.15 | 45.45 | 45.41 | - | 23.34 |
Receivables | 365.86 | 206.55 | 130 | 111.28 | 191.66 |
Inventory | 364.43 | 287.51 | 298.11 | 249.22 | 331.39 |
Prepaid Expenses | - | 4.65 | 7.58 | 53.88 | 59.7 |
Other Current Assets | 89.11 | 69.03 | 49.94 | 47.95 | 103.04 |
Total Current Assets | 1,169 | 784.59 | 656.63 | 651.63 | 963.32 |
Property, Plant & Equipment | 384.73 | 400.59 | 443.37 | 540.67 | 688.27 |
Long-Term Investments | 548.74 | 285.21 | 699.45 | 554.75 | 1,043 |
Goodwill | 3.9 | 4.37 | 4.37 | 3.9 | 3.9 |
Other Intangible Assets | 1,345 | 311.63 | 282.36 | 293.75 | 302.26 |
Long-Term Deferred Tax Assets | 11.91 | 8.1 | 10.2 | 7.58 | 15.42 |
Long-Term Deferred Charges | - | 823.39 | 794.29 | 729.74 | 620.26 |
Total Assets | 3,464 | 2,618 | 2,891 | 2,782 | 3,637 |
Accounts Payable | 174.63 | 141.97 | 74.15 | 101.3 | 62.6 |
Short-Term Debt | - | 42.32 | 25.39 | - | 12.26 |
Current Portion of Long-Term Debt | 214.06 | 107.64 | 96.73 | 76.73 | 150.28 |
Current Portion of Leases | 9.1 | 7.8 | 7.45 | 6.83 | 12.64 |
Current Income Taxes Payable | 2.24 | 8.77 | 6.08 | 3.06 | 0.13 |
Other Current Liabilities | 730.16 | 462.76 | 439.02 | 462.18 | 684.67 |
Total Current Liabilities | 1,130 | 771.25 | 648.82 | 650.1 | 922.58 |
Long-Term Debt | 81.57 | 63.91 | 70.64 | 77.36 | 84.09 |
Long-Term Leases | 5.54 | 5.63 | 3.93 | 2.57 | 7.87 |
Pension & Post-Retirement Benefits | 135.71 | 122.79 | 110.1 | 96.23 | 111.97 |
Long-Term Deferred Tax Liabilities | 106.32 | 84.23 | 73.43 | 73.9 | 79.23 |
Other Long-Term Liabilities | 104.3 | 21.15 | 23.15 | 39.34 | 40 |
Total Liabilities | 1,564 | 1,069 | 930.07 | 939.5 | 1,246 |
Common Stock | 29.44 | 29.44 | 29.44 | 29.44 | 29.44 |
Additional Paid-In Capital | 720.09 | 720.09 | 720.09 | 720.09 | 720.09 |
Retained Earnings | 3,711 | 3,642 | 3,561 | 3,544 | 3,511 |
Comprehensive Income & Other | -2,415 | -2,739 | -2,271 | -2,369 | -1,796 |
Total Common Equity | 2,046 | 1,652 | 2,039 | 1,924 | 2,465 |
Minority Interest | -145.58 | -102.89 | -78.36 | -81.58 | -73.42 |
Shareholders' Equity | 1,900 | 1,549 | 1,961 | 1,843 | 2,391 |
Total Liabilities & Equity | 3,464 | 2,618 | 2,891 | 2,782 | 3,637 |
Total Debt | 310.27 | 227.3 | 204.14 | 163.49 | 267.14 |
Net Cash (Debt) | 39.63 | -10.45 | -33.14 | 25.81 | 10.39 |
Net Cash Growth | - | - | - | 148.36% | -95.97% |
Net Cash Per Share | 0.07 | -0.02 | -0.06 | 0.04 | 0.02 |
Filing Date Shares Outstanding | 588.84 | 588.84 | 588.84 | 588.84 | 588.84 |
Total Common Shares Outstanding | 588.84 | 588.84 | 588.84 | 588.84 | 588.84 |
Working Capital | 39.09 | 13.33 | 7.81 | 1.53 | 40.74 |
Book Value Per Share | 3.47 | 2.81 | 3.46 | 3.27 | 4.19 |
Tangible Book Value | 696.61 | 1,336 | 1,752 | 1,626 | 2,158 |
Tangible Book Value Per Share | 1.18 | 2.27 | 2.98 | 2.76 | 3.67 |
Buildings | - | 217.54 | 225.35 | 232.29 | 259.65 |
Machinery | - | 571.77 | 561.37 | 548.42 | 572.66 |
Construction In Progress | - | 24.18 | 24.78 | 38.62 | 52.57 |
Leasehold Improvements | - | 71.46 | 75.69 | 75.75 | 81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.